nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ABCC4—Nateglinide—type 2 diabetes mellitus	0.113	0.411	CbGbCtD
Dipyridamole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0449	0.163	CbGbCtD
Dipyridamole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0401	0.145	CbGbCtD
Dipyridamole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.029	0.105	CbGbCtD
Dipyridamole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0199	0.0722	CbGbCtD
Dipyridamole—ABCB1—Glyburide—type 2 diabetes mellitus	0.0148	0.0538	CbGbCtD
Dipyridamole—ABCB1—Losartan—type 2 diabetes mellitus	0.0136	0.0492	CbGbCtD
Dipyridamole—PDE3B—brown adipose tissue—type 2 diabetes mellitus	0.00922	0.0618	CbGeAlD
Dipyridamole—PDE8B—leg—type 2 diabetes mellitus	0.0076	0.0509	CbGeAlD
Dipyridamole—ADA—brown adipose tissue—type 2 diabetes mellitus	0.00699	0.0468	CbGeAlD
Dipyridamole—PDE8B—hindlimb—type 2 diabetes mellitus	0.00678	0.0455	CbGeAlD
Dipyridamole—PDE5A—penis—type 2 diabetes mellitus	0.00551	0.0369	CbGeAlD
Dipyridamole—PDE3A—penis—type 2 diabetes mellitus	0.00536	0.0359	CbGeAlD
Dipyridamole—PDE6A—retina—type 2 diabetes mellitus	0.00493	0.033	CbGeAlD
Dipyridamole—PDE6C—retina—type 2 diabetes mellitus	0.00467	0.0313	CbGeAlD
Dipyridamole—PDE6B—retina—type 2 diabetes mellitus	0.00296	0.0199	CbGeAlD
Dipyridamole—PRUNE—nephron tubule—type 2 diabetes mellitus	0.00294	0.0197	CbGeAlD
Dipyridamole—PDE1C—cardiovascular system—type 2 diabetes mellitus	0.00292	0.0196	CbGeAlD
Dipyridamole—PDE6D—nephron tubule—type 2 diabetes mellitus	0.00284	0.019	CbGeAlD
Dipyridamole—PDE6H—retina—type 2 diabetes mellitus	0.00275	0.0185	CbGeAlD
Dipyridamole—PDE6G—retina—type 2 diabetes mellitus	0.00265	0.0178	CbGeAlD
Dipyridamole—PDE5A—artery—type 2 diabetes mellitus	0.00255	0.0171	CbGeAlD
Dipyridamole—PRUNE—cortex of kidney—type 2 diabetes mellitus	0.00251	0.0168	CbGeAlD
Dipyridamole—PDE6D—cortex of kidney—type 2 diabetes mellitus	0.00243	0.0163	CbGeAlD
Dipyridamole—PRUNE—adipose tissue—type 2 diabetes mellitus	0.00233	0.0156	CbGeAlD
Dipyridamole—PDE6D—adipose tissue—type 2 diabetes mellitus	0.00225	0.0151	CbGeAlD
Dipyridamole—PDE5A—endothelium—type 2 diabetes mellitus	0.00215	0.0144	CbGeAlD
Dipyridamole—PDE7A—kidney—type 2 diabetes mellitus	0.00203	0.0136	CbGeAlD
Dipyridamole—PDE8B—islet of Langerhans—type 2 diabetes mellitus	0.002	0.0134	CbGeAlD
Dipyridamole—PDE3B—islet of Langerhans—type 2 diabetes mellitus	0.00195	0.0131	CbGeAlD
Dipyridamole—PDE8A—islet of Langerhans—type 2 diabetes mellitus	0.0018	0.012	CbGeAlD
Dipyridamole—PDE10A—nephron tubule—type 2 diabetes mellitus	0.00169	0.0113	CbGeAlD
Dipyridamole—PRUNE—liver—type 2 diabetes mellitus	0.00163	0.0109	CbGeAlD
Dipyridamole—PDE7B—adipose tissue—type 2 diabetes mellitus	0.0016	0.0107	CbGeAlD
Dipyridamole—PDE6D—liver—type 2 diabetes mellitus	0.00158	0.0106	CbGeAlD
Dipyridamole—PDE2A—cardiovascular system—type 2 diabetes mellitus	0.00151	0.0102	CbGeAlD
Dipyridamole—PDE8A—nephron tubule—type 2 diabetes mellitus	0.00145	0.0097	CbGeAlD
Dipyridamole—PDE2A—cortex of kidney—type 2 diabetes mellitus	0.00144	0.00967	CbGeAlD
Dipyridamole—PDE11A—liver—type 2 diabetes mellitus	0.00144	0.00966	CbGeAlD
Dipyridamole—PDE3B—cardiovascular system—type 2 diabetes mellitus	0.00141	0.00946	CbGeAlD
Dipyridamole—PDE1A—nephron tubule—type 2 diabetes mellitus	0.0014	0.00939	CbGeAlD
Dipyridamole—PDE6G—liver—type 2 diabetes mellitus	0.00139	0.00929	CbGeAlD
Dipyridamole—PDE3B—pancreas—type 2 diabetes mellitus	0.00137	0.00919	CbGeAlD
Dipyridamole—PDE2A—adipose tissue—type 2 diabetes mellitus	0.00134	0.00895	CbGeAlD
Dipyridamole—PDE10A—adipose tissue—type 2 diabetes mellitus	0.00134	0.00895	CbGeAlD
Dipyridamole—PDE1B—adipose tissue—type 2 diabetes mellitus	0.00132	0.00887	CbGeAlD
Dipyridamole—PDE8B—adipose tissue—type 2 diabetes mellitus	0.00127	0.00854	CbGeAlD
Dipyridamole—PDE8A—pancreas—type 2 diabetes mellitus	0.00126	0.00847	CbGeAlD
Dipyridamole—PDE1A—cardiovascular system—type 2 diabetes mellitus	0.00126	0.00843	CbGeAlD
Dipyridamole—PDE3B—adipose tissue—type 2 diabetes mellitus	0.00124	0.00834	CbGeAlD
Dipyridamole—PDE8A—cortex of kidney—type 2 diabetes mellitus	0.00124	0.0083	CbGeAlD
Dipyridamole—PDE1A—kidney—type 2 diabetes mellitus	0.00123	0.00825	CbGeAlD
Dipyridamole—PDE1A—cortex of kidney—type 2 diabetes mellitus	0.0012	0.00803	CbGeAlD
Dipyridamole—PDE8A—adipose tissue—type 2 diabetes mellitus	0.00115	0.00768	CbGeAlD
Dipyridamole—PDE7B—liver—type 2 diabetes mellitus	0.00112	0.00752	CbGeAlD
Dipyridamole—PDE1A—adipose tissue—type 2 diabetes mellitus	0.00111	0.00743	CbGeAlD
Dipyridamole—ADA—cardiovascular system—type 2 diabetes mellitus	0.00107	0.00717	CbGeAlD
Dipyridamole—PDE5A—retina—type 2 diabetes mellitus	0.00105	0.00702	CbGeAlD
Dipyridamole—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.00103	0.0069	CbGeAlD
Dipyridamole—ABCC5—retina—type 2 diabetes mellitus	0.000958	0.00642	CbGeAlD
Dipyridamole—ADA—adipose tissue—type 2 diabetes mellitus	0.000943	0.00632	CbGeAlD
Dipyridamole—PDE2A—liver—type 2 diabetes mellitus	0.000937	0.00628	CbGeAlD
Dipyridamole—PDE4A—adipose tissue—type 2 diabetes mellitus	0.000919	0.00616	CbGeAlD
Dipyridamole—ABCC5—nephron tubule—type 2 diabetes mellitus	0.000903	0.00605	CbGeAlD
Dipyridamole—PDE8B—liver—type 2 diabetes mellitus	0.000894	0.00599	CbGeAlD
Dipyridamole—PDE5A—cardiovascular system—type 2 diabetes mellitus	0.000886	0.00594	CbGeAlD
Dipyridamole—PDE3B—liver—type 2 diabetes mellitus	0.000873	0.00585	CbGeAlD
Dipyridamole—PDE3A—cardiovascular system—type 2 diabetes mellitus	0.000862	0.00578	CbGeAlD
Dipyridamole—PDE8A—liver—type 2 diabetes mellitus	0.000804	0.00539	CbGeAlD
Dipyridamole—PDE5A—adipose tissue—type 2 diabetes mellitus	0.000782	0.00524	CbGeAlD
Dipyridamole—PDE1A—liver—type 2 diabetes mellitus	0.000778	0.00521	CbGeAlD
Dipyridamole—PDE3A—adipose tissue—type 2 diabetes mellitus	0.00076	0.0051	CbGeAlD
Dipyridamole—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.000744	0.00499	CbGeAlD
Dipyridamole—SLC29A1—kidney—type 2 diabetes mellitus	0.000728	0.00488	CbGeAlD
Dipyridamole—SLC29A1—pancreas—type 2 diabetes mellitus	0.000723	0.00485	CbGeAlD
Dipyridamole—ABCC5—adipose tissue—type 2 diabetes mellitus	0.000715	0.00479	CbGeAlD
Dipyridamole—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.000709	0.00475	CbGeAlD
Dipyridamole—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.000656	0.0044	CbGeAlD
Dipyridamole—ABCC4—nephron tubule—type 2 diabetes mellitus	0.000626	0.00419	CbGeAlD
Dipyridamole—ABCC4—kidney—type 2 diabetes mellitus	0.00055	0.00368	CbGeAlD
Dipyridamole—ABCC4—pancreas—type 2 diabetes mellitus	0.000546	0.00366	CbGeAlD
Dipyridamole—ABCC4—cortex of kidney—type 2 diabetes mellitus	0.000535	0.00359	CbGeAlD
Dipyridamole—PDE3A—liver—type 2 diabetes mellitus	0.000533	0.00357	CbGeAlD
Dipyridamole—ABCC5—liver—type 2 diabetes mellitus	0.000501	0.00336	CbGeAlD
Dipyridamole—ABCC4—adipose tissue—type 2 diabetes mellitus	0.000495	0.00332	CbGeAlD
Dipyridamole—SLC29A1—liver—type 2 diabetes mellitus	0.00046	0.00308	CbGeAlD
Dipyridamole—ABCC4—liver—type 2 diabetes mellitus	0.000347	0.00233	CbGeAlD
Dipyridamole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.00027	0.00181	CbGeAlD
Dipyridamole—ABCB1—retina—type 2 diabetes mellitus	0.000231	0.00155	CbGeAlD
Dipyridamole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000218	0.00146	CbGeAlD
Dipyridamole—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000196	0.00131	CbGeAlD
Dipyridamole—ABCB1—kidney—type 2 diabetes mellitus	0.000191	0.00128	CbGeAlD
Dipyridamole—ABCB1—pancreas—type 2 diabetes mellitus	0.00019	0.00127	CbGeAlD
Dipyridamole—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000186	0.00125	CbGeAlD
Dipyridamole—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000185	0.0006	CcSEcCtD
Dipyridamole—Pain—Gliclazide—type 2 diabetes mellitus	0.000185	0.0006	CcSEcCtD
Dipyridamole—Tremor—Losartan—type 2 diabetes mellitus	0.000185	0.000598	CcSEcCtD
Dipyridamole—Rash—Glimepiride—type 2 diabetes mellitus	0.000184	0.000597	CcSEcCtD
Dipyridamole—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000184	0.000597	CcSEcCtD
Dipyridamole—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000184	0.000596	CcSEcCtD
Dipyridamole—Rash—Sitagliptin—type 2 diabetes mellitus	0.000184	0.000595	CcSEcCtD
Dipyridamole—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000183	0.000595	CcSEcCtD
Dipyridamole—Headache—Glimepiride—type 2 diabetes mellitus	0.000183	0.000593	CcSEcCtD
Dipyridamole—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000183	0.000592	CcSEcCtD
Dipyridamole—Cough—Irbesartan—type 2 diabetes mellitus	0.000183	0.000592	CcSEcCtD
Dipyridamole—Headache—Sitagliptin—type 2 diabetes mellitus	0.000182	0.000591	CcSEcCtD
Dipyridamole—Anaemia—Losartan—type 2 diabetes mellitus	0.000182	0.00059	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000181	0.000587	CcSEcCtD
Dipyridamole—Oedema—Metformin—type 2 diabetes mellitus	0.000181	0.000587	CcSEcCtD
Dipyridamole—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000181	0.000586	CcSEcCtD
Dipyridamole—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000181	0.000586	CcSEcCtD
Dipyridamole—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.00018	0.000585	CcSEcCtD
Dipyridamole—Flushing—Ramipril—type 2 diabetes mellitus	0.00018	0.000584	CcSEcCtD
Dipyridamole—Angioedema—Losartan—type 2 diabetes mellitus	0.00018	0.000583	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000179	0.00058	CcSEcCtD
Dipyridamole—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000178	0.000579	CcSEcCtD
Dipyridamole—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000178	0.000578	CcSEcCtD
Dipyridamole—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000178	0.000578	CcSEcCtD
Dipyridamole—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000178	0.000578	CcSEcCtD
Dipyridamole—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000178	0.000578	CcSEcCtD
Dipyridamole—Shock—Metformin—type 2 diabetes mellitus	0.000178	0.000577	CcSEcCtD
Dipyridamole—Malaise—Losartan—type 2 diabetes mellitus	0.000178	0.000576	CcSEcCtD
Dipyridamole—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000178	0.000576	CcSEcCtD
Dipyridamole—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000177	0.000575	CcSEcCtD
Dipyridamole—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000177	0.000575	CcSEcCtD
Dipyridamole—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000177	0.000575	CcSEcCtD
Dipyridamole—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000177	0.000574	CcSEcCtD
Dipyridamole—Vertigo—Losartan—type 2 diabetes mellitus	0.000177	0.000574	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000177	0.000574	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000177	0.000574	CcSEcCtD
Dipyridamole—Somnolence—Valsartan—type 2 diabetes mellitus	0.000177	0.000573	CcSEcCtD
Dipyridamole—Syncope—Losartan—type 2 diabetes mellitus	0.000177	0.000573	CcSEcCtD
Dipyridamole—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000176	0.000572	CcSEcCtD
Dipyridamole—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000176	0.000571	CcSEcCtD
Dipyridamole—Skin disorder—Metformin—type 2 diabetes mellitus	0.000176	0.00057	CcSEcCtD
Dipyridamole—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000175	0.000568	CcSEcCtD
Dipyridamole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000175	0.000567	CcSEcCtD
Dipyridamole—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000175	0.000567	CcSEcCtD
Dipyridamole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000175	0.000567	CcSEcCtD
Dipyridamole—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000174	0.000565	CcSEcCtD
Dipyridamole—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000174	0.000565	CcSEcCtD
Dipyridamole—Palpitations—Losartan—type 2 diabetes mellitus	0.000174	0.000564	CcSEcCtD
Dipyridamole—Nausea—Glimepiride—type 2 diabetes mellitus	0.000173	0.000563	CcSEcCtD
Dipyridamole—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000173	0.000562	CcSEcCtD
Dipyridamole—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000173	0.000561	CcSEcCtD
Dipyridamole—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000173	0.000561	CcSEcCtD
Dipyridamole—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000173	0.00056	CcSEcCtD
Dipyridamole—Asthenia—Glyburide—type 2 diabetes mellitus	0.000173	0.00056	CcSEcCtD
Dipyridamole—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000172	0.00116	CbGeAlD
Dipyridamole—Cough—Losartan—type 2 diabetes mellitus	0.000172	0.000557	CcSEcCtD
Dipyridamole—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000172	0.000557	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000172	0.000556	CcSEcCtD
Dipyridamole—Alopecia—Ramipril—type 2 diabetes mellitus	0.000171	0.000556	CcSEcCtD
Dipyridamole—Fatigue—Valsartan—type 2 diabetes mellitus	0.000171	0.000556	CcSEcCtD
Dipyridamole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000171	0.000554	CcSEcCtD
Dipyridamole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000171	0.000554	CcSEcCtD
Dipyridamole—Oedema—Irbesartan—type 2 diabetes mellitus	0.000171	0.000554	CcSEcCtD
Dipyridamole—Pruritus—Glyburide—type 2 diabetes mellitus	0.00017	0.000553	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00017	0.00055	CcSEcCtD
Dipyridamole—Fatigue—Orlistat—type 2 diabetes mellitus	0.000169	0.000549	CcSEcCtD
Dipyridamole—Hypotension—Metformin—type 2 diabetes mellitus	0.000169	0.000548	CcSEcCtD
Dipyridamole—Shock—Irbesartan—type 2 diabetes mellitus	0.000168	0.000545	CcSEcCtD
Dipyridamole—Pain—Orlistat—type 2 diabetes mellitus	0.000168	0.000544	CcSEcCtD
Dipyridamole—Chest pain—Losartan—type 2 diabetes mellitus	0.000168	0.000544	CcSEcCtD
Dipyridamole—Arthralgia—Losartan—type 2 diabetes mellitus	0.000168	0.000544	CcSEcCtD
Dipyridamole—Myalgia—Losartan—type 2 diabetes mellitus	0.000168	0.000544	CcSEcCtD
Dipyridamole—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000168	0.000543	CcSEcCtD
Dipyridamole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000167	0.000543	CcSEcCtD
Dipyridamole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000167	0.000542	CcSEcCtD
Dipyridamole—Anxiety—Losartan—type 2 diabetes mellitus	0.000167	0.000542	CcSEcCtD
Dipyridamole—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000167	0.00054	CcSEcCtD
Dipyridamole—Rash—Bromocriptine—type 2 diabetes mellitus	0.000166	0.000539	CcSEcCtD
Dipyridamole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000166	0.000538	CcSEcCtD
Dipyridamole—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000166	0.000538	CcSEcCtD
Dipyridamole—Tension—Ramipril—type 2 diabetes mellitus	0.000166	0.000537	CcSEcCtD
Dipyridamole—Discomfort—Losartan—type 2 diabetes mellitus	0.000166	0.000537	CcSEcCtD
Dipyridamole—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000165	0.000536	CcSEcCtD
Dipyridamole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000165	0.000535	CcSEcCtD
Dipyridamole—Headache—Bromocriptine—type 2 diabetes mellitus	0.000165	0.000535	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000165	0.000535	CcSEcCtD
Dipyridamole—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000165	0.000534	CcSEcCtD
Dipyridamole—Nervousness—Ramipril—type 2 diabetes mellitus	0.000164	0.000532	CcSEcCtD
Dipyridamole—Dry mouth—Losartan—type 2 diabetes mellitus	0.000164	0.000532	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000163	0.000527	CcSEcCtD
Dipyridamole—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000163	0.000527	CcSEcCtD
Dipyridamole—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000162	0.000526	CcSEcCtD
Dipyridamole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000162	0.000525	CcSEcCtD
Dipyridamole—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000161	0.000523	CcSEcCtD
Dipyridamole—Somnolence—Metformin—type 2 diabetes mellitus	0.000161	0.000522	CcSEcCtD
Dipyridamole—Oedema—Losartan—type 2 diabetes mellitus	0.000161	0.000521	CcSEcCtD
Dipyridamole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000161	0.000521	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000161	0.000521	CcSEcCtD
Dipyridamole—Hypotension—Irbesartan—type 2 diabetes mellitus	0.00016	0.000517	CcSEcCtD
Dipyridamole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000159	0.000517	CcSEcCtD
Dipyridamole—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000159	0.000517	CcSEcCtD
Dipyridamole—Tremor—Ramipril—type 2 diabetes mellitus	0.000158	0.000513	CcSEcCtD
Dipyridamole—Shock—Losartan—type 2 diabetes mellitus	0.000158	0.000513	CcSEcCtD
Dipyridamole—Urticaria—Valsartan—type 2 diabetes mellitus	0.000158	0.000512	CcSEcCtD
Dipyridamole—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000158	0.000511	CcSEcCtD
Dipyridamole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000157	0.00051	CcSEcCtD
Dipyridamole—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000157	0.000509	CcSEcCtD
Dipyridamole—Tachycardia—Losartan—type 2 diabetes mellitus	0.000157	0.000509	CcSEcCtD
Dipyridamole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000157	0.000508	CcSEcCtD
Dipyridamole—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000157	0.000508	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000156	0.000507	CcSEcCtD
Dipyridamole—Fatigue—Metformin—type 2 diabetes mellitus	0.000156	0.000506	CcSEcCtD
Dipyridamole—Urticaria—Orlistat—type 2 diabetes mellitus	0.000156	0.000506	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000156	0.000505	CcSEcCtD
Dipyridamole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000155	0.000504	CcSEcCtD
Dipyridamole—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000155	0.000503	CcSEcCtD
Dipyridamole—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000155	0.000503	CcSEcCtD
Dipyridamole—Angioedema—Ramipril—type 2 diabetes mellitus	0.000154	0.0005	CcSEcCtD
Dipyridamole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000153	0.000497	CcSEcCtD
Dipyridamole—Vomiting—Glyburide—type 2 diabetes mellitus	0.000153	0.000497	CcSEcCtD
Dipyridamole—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000153	0.000496	CcSEcCtD
Dipyridamole—Malaise—Ramipril—type 2 diabetes mellitus	0.000152	0.000494	CcSEcCtD
Dipyridamole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000152	0.000494	CcSEcCtD
Dipyridamole—Rash—Glyburide—type 2 diabetes mellitus	0.000152	0.000492	CcSEcCtD
Dipyridamole—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000152	0.000492	CcSEcCtD
Dipyridamole—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000152	0.000492	CcSEcCtD
Dipyridamole—Vertigo—Ramipril—type 2 diabetes mellitus	0.000152	0.000492	CcSEcCtD
Dipyridamole—Syncope—Ramipril—type 2 diabetes mellitus	0.000151	0.000491	CcSEcCtD
Dipyridamole—Headache—Glyburide—type 2 diabetes mellitus	0.000151	0.000489	CcSEcCtD
Dipyridamole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.00015	0.000487	CcSEcCtD
Dipyridamole—Hypotension—Losartan—type 2 diabetes mellitus	0.00015	0.000487	CcSEcCtD
Dipyridamole—Palpitations—Ramipril—type 2 diabetes mellitus	0.000149	0.000484	CcSEcCtD
Dipyridamole—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000149	0.000484	CcSEcCtD
Dipyridamole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000148	0.000481	CcSEcCtD
Dipyridamole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000148	0.00048	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000148	0.00048	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000147	0.000478	CcSEcCtD
Dipyridamole—Cough—Ramipril—type 2 diabetes mellitus	0.000147	0.000478	CcSEcCtD
Dipyridamole—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000147	0.000477	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000146	0.000475	CcSEcCtD
Dipyridamole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000146	0.000475	CcSEcCtD
Dipyridamole—Convulsion—Ramipril—type 2 diabetes mellitus	0.000146	0.000474	CcSEcCtD
Dipyridamole—Pain—Irbesartan—type 2 diabetes mellitus	0.000146	0.000474	CcSEcCtD
Dipyridamole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000145	0.000469	CcSEcCtD
Dipyridamole—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000144	0.000468	CcSEcCtD
Dipyridamole—Urticaria—Metformin—type 2 diabetes mellitus	0.000144	0.000466	CcSEcCtD
Dipyridamole—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000144	0.000466	CcSEcCtD
Dipyridamole—Chest pain—Ramipril—type 2 diabetes mellitus	0.000144	0.000466	CcSEcCtD
Dipyridamole—Myalgia—Ramipril—type 2 diabetes mellitus	0.000144	0.000466	CcSEcCtD
Dipyridamole—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000143	0.000465	CcSEcCtD
Dipyridamole—Anxiety—Ramipril—type 2 diabetes mellitus	0.000143	0.000465	CcSEcCtD
Dipyridamole—Nausea—Glyburide—type 2 diabetes mellitus	0.000143	0.000464	CcSEcCtD
Dipyridamole—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000143	0.000464	CcSEcCtD
Dipyridamole—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000143	0.000464	CcSEcCtD
Dipyridamole—Somnolence—Losartan—type 2 diabetes mellitus	0.000143	0.000463	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000143	0.000463	CcSEcCtD
Dipyridamole—Asthenia—Valsartan—type 2 diabetes mellitus	0.000143	0.000462	CcSEcCtD
Dipyridamole—Discomfort—Ramipril—type 2 diabetes mellitus	0.000142	0.000461	CcSEcCtD
Dipyridamole—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000141	0.000459	CcSEcCtD
Dipyridamole—Asthenia—Orlistat—type 2 diabetes mellitus	0.000141	0.000457	CcSEcCtD
Dipyridamole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000141	0.000456	CcSEcCtD
Dipyridamole—Pruritus—Valsartan—type 2 diabetes mellitus	0.000141	0.000456	CcSEcCtD
Dipyridamole—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000141	0.000456	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00014	0.000453	CcSEcCtD
Dipyridamole—Pruritus—Orlistat—type 2 diabetes mellitus	0.000139	0.00045	CcSEcCtD
Dipyridamole—Fatigue—Losartan—type 2 diabetes mellitus	0.000139	0.000449	CcSEcCtD
Dipyridamole—Oedema—Ramipril—type 2 diabetes mellitus	0.000138	0.000447	CcSEcCtD
Dipyridamole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000138	0.000447	CcSEcCtD
Dipyridamole—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000138	0.000446	CcSEcCtD
Dipyridamole—Pain—Losartan—type 2 diabetes mellitus	0.000137	0.000446	CcSEcCtD
Dipyridamole—Rash—Gliclazide—type 2 diabetes mellitus	0.000136	0.000442	CcSEcCtD
Dipyridamole—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000136	0.000442	CcSEcCtD
Dipyridamole—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000136	0.000441	CcSEcCtD
Dipyridamole—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000136	0.00044	CcSEcCtD
Dipyridamole—Shock—Ramipril—type 2 diabetes mellitus	0.000136	0.00044	CcSEcCtD
Dipyridamole—Headache—Gliclazide—type 2 diabetes mellitus	0.000136	0.000439	CcSEcCtD
Dipyridamole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.000438	CcSEcCtD
Dipyridamole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000135	0.000438	CcSEcCtD
Dipyridamole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000135	0.000438	CcSEcCtD
Dipyridamole—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000135	0.000436	CcSEcCtD
Dipyridamole—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000134	0.000436	CcSEcCtD
Dipyridamole—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000134	0.000434	CcSEcCtD
Dipyridamole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000133	0.000432	CcSEcCtD
Dipyridamole—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000132	0.000429	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000131	0.000426	CcSEcCtD
Dipyridamole—Dizziness—Valsartan—type 2 diabetes mellitus	0.000131	0.000426	CcSEcCtD
Dipyridamole—Dizziness—Orlistat—type 2 diabetes mellitus	0.00013	0.000421	CcSEcCtD
Dipyridamole—Asthenia—Metformin—type 2 diabetes mellitus	0.00013	0.000421	CcSEcCtD
Dipyridamole—Hypotension—Ramipril—type 2 diabetes mellitus	0.000129	0.000418	CcSEcCtD
Dipyridamole—Nausea—Gliclazide—type 2 diabetes mellitus	0.000128	0.000417	CcSEcCtD
Dipyridamole—Pruritus—Metformin—type 2 diabetes mellitus	0.000128	0.000415	CcSEcCtD
Dipyridamole—Urticaria—Losartan—type 2 diabetes mellitus	0.000128	0.000414	CcSEcCtD
Dipyridamole—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000127	0.000412	CcSEcCtD
Dipyridamole—Vomiting—Valsartan—type 2 diabetes mellitus	0.000126	0.00041	CcSEcCtD
Dipyridamole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000126	0.000408	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000126	0.000407	CcSEcCtD
Dipyridamole—Rash—Valsartan—type 2 diabetes mellitus	0.000125	0.000406	CcSEcCtD
Dipyridamole—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000125	0.000406	CcSEcCtD
Dipyridamole—Vomiting—Orlistat—type 2 diabetes mellitus	0.000125	0.000405	CcSEcCtD
Dipyridamole—Headache—Valsartan—type 2 diabetes mellitus	0.000124	0.000404	CcSEcCtD
Dipyridamole—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000124	0.000401	CcSEcCtD
Dipyridamole—Rash—Orlistat—type 2 diabetes mellitus	0.000124	0.000401	CcSEcCtD
Dipyridamole—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000124	0.000401	CcSEcCtD
Dipyridamole—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000124	0.000401	CcSEcCtD
Dipyridamole—Headache—Orlistat—type 2 diabetes mellitus	0.000123	0.000399	CcSEcCtD
Dipyridamole—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000123	0.000398	CcSEcCtD
Dipyridamole—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000123	0.000397	CcSEcCtD
Dipyridamole—Somnolence—Ramipril—type 2 diabetes mellitus	0.000123	0.000397	CcSEcCtD
Dipyridamole—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000121	0.000393	CcSEcCtD
Dipyridamole—ABCB1—liver—type 2 diabetes mellitus	0.000121	0.000811	CbGeAlD
Dipyridamole—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000121	0.000392	CcSEcCtD
Dipyridamole—Dizziness—Metformin—type 2 diabetes mellitus	0.00012	0.000388	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000119	0.000386	CcSEcCtD
Dipyridamole—Fatigue—Ramipril—type 2 diabetes mellitus	0.000119	0.000385	CcSEcCtD
Dipyridamole—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000118	0.000384	CcSEcCtD
Dipyridamole—Nausea—Valsartan—type 2 diabetes mellitus	0.000118	0.000383	CcSEcCtD
Dipyridamole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000117	0.000379	CcSEcCtD
Dipyridamole—Nausea—Orlistat—type 2 diabetes mellitus	0.000117	0.000378	CcSEcCtD
Dipyridamole—Asthenia—Losartan—type 2 diabetes mellitus	0.000115	0.000374	CcSEcCtD
Dipyridamole—Vomiting—Metformin—type 2 diabetes mellitus	0.000115	0.000373	CcSEcCtD
Dipyridamole—Rash—Metformin—type 2 diabetes mellitus	0.000114	0.00037	CcSEcCtD
Dipyridamole—Dermatitis—Metformin—type 2 diabetes mellitus	0.000114	0.00037	CcSEcCtD
Dipyridamole—Pruritus—Losartan—type 2 diabetes mellitus	0.000114	0.000369	CcSEcCtD
Dipyridamole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000114	0.000368	CcSEcCtD
Dipyridamole—Headache—Metformin—type 2 diabetes mellitus	0.000113	0.000368	CcSEcCtD
Dipyridamole—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000113	0.000366	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000113	0.000365	CcSEcCtD
Dipyridamole—Diarrhoea—Losartan—type 2 diabetes mellitus	0.00011	0.000357	CcSEcCtD
Dipyridamole—Urticaria—Ramipril—type 2 diabetes mellitus	0.000109	0.000355	CcSEcCtD
Dipyridamole—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000109	0.000353	CcSEcCtD
Dipyridamole—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000109	0.000352	CcSEcCtD
Dipyridamole—Rash—Irbesartan—type 2 diabetes mellitus	0.000108	0.000349	CcSEcCtD
Dipyridamole—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000108	0.000349	CcSEcCtD
Dipyridamole—Nausea—Metformin—type 2 diabetes mellitus	0.000107	0.000349	CcSEcCtD
Dipyridamole—Headache—Irbesartan—type 2 diabetes mellitus	0.000107	0.000347	CcSEcCtD
Dipyridamole—Dizziness—Losartan—type 2 diabetes mellitus	0.000106	0.000345	CcSEcCtD
Dipyridamole—Vomiting—Losartan—type 2 diabetes mellitus	0.000102	0.000331	CcSEcCtD
Dipyridamole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000102	0.000329	CcSEcCtD
Dipyridamole—Nausea—Irbesartan—type 2 diabetes mellitus	0.000101	0.000329	CcSEcCtD
Dipyridamole—Rash—Losartan—type 2 diabetes mellitus	0.000101	0.000329	CcSEcCtD
Dipyridamole—Dermatitis—Losartan—type 2 diabetes mellitus	0.000101	0.000328	CcSEcCtD
Dipyridamole—Headache—Losartan—type 2 diabetes mellitus	0.000101	0.000326	CcSEcCtD
Dipyridamole—Asthenia—Ramipril—type 2 diabetes mellitus	9.89e-05	0.000321	CcSEcCtD
Dipyridamole—Pruritus—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000316	CcSEcCtD
Dipyridamole—Nausea—Losartan—type 2 diabetes mellitus	9.55e-05	0.00031	CcSEcCtD
Dipyridamole—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.43e-05	0.000306	CcSEcCtD
Dipyridamole—Dizziness—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000295	CcSEcCtD
Dipyridamole—Vomiting—Ramipril—type 2 diabetes mellitus	8.76e-05	0.000284	CcSEcCtD
Dipyridamole—Rash—Ramipril—type 2 diabetes mellitus	8.69e-05	0.000282	CcSEcCtD
Dipyridamole—Dermatitis—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000281	CcSEcCtD
Dipyridamole—Headache—Ramipril—type 2 diabetes mellitus	8.63e-05	0.00028	CcSEcCtD
Dipyridamole—Nausea—Ramipril—type 2 diabetes mellitus	8.19e-05	0.000265	CcSEcCtD
Dipyridamole—PDE10A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.04e-06	2.64e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	6.99e-06	2.62e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.97e-06	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.97e-06	2.61e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.94e-06	2.6e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	6.89e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	6.87e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	6.87e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	6.87e-06	2.58e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.86e-06	2.57e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.82e-06	2.55e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.77e-06	2.54e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—type 2 diabetes mellitus	6.77e-06	2.54e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.75e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—INS—type 2 diabetes mellitus	6.75e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AGT—type 2 diabetes mellitus	6.75e-06	2.53e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.72e-06	2.52e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—type 2 diabetes mellitus	6.71e-06	2.52e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—type 2 diabetes mellitus	6.67e-06	2.5e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—NFKB1—type 2 diabetes mellitus	6.65e-06	2.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	6.65e-06	2.49e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.64e-06	2.49e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.63e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.63e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.62e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	6.61e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—LEP—type 2 diabetes mellitus	6.61e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOE—type 2 diabetes mellitus	6.61e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—type 2 diabetes mellitus	6.61e-06	2.48e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—type 2 diabetes mellitus	6.59e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.59e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.59e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—type 2 diabetes mellitus	6.58e-06	2.47e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—INS—type 2 diabetes mellitus	6.57e-06	2.46e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	6.56e-06	2.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—type 2 diabetes mellitus	6.55e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.53e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.53e-06	2.45e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.52e-06	2.44e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.5e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.5e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—NOS3—type 2 diabetes mellitus	6.47e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PIK3R1—type 2 diabetes mellitus	6.47e-06	2.43e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—PTGS2—type 2 diabetes mellitus	6.47e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	6.46e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.46e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	6.46e-06	2.42e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.45e-06	2.41e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.42e-06	2.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.35e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.35e-06	2.38e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	6.34e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.33e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	6.33e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.32e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.32e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.32e-06	2.37e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.23e-06	2.33e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	6.2e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.2e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—SRC—type 2 diabetes mellitus	6.19e-06	2.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.17e-06	2.31e-05	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.08e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.08e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—NFKB1—type 2 diabetes mellitus	6.08e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.07e-06	2.28e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	6.05e-06	2.27e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—type 2 diabetes mellitus	6.04e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.03e-06	2.26e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.97e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.97e-06	2.24e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—RELA—type 2 diabetes mellitus	5.95e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.94e-06	2.23e-05	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.93e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.92e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—PTGS2—type 2 diabetes mellitus	5.92e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.92e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.92e-06	2.22e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	5.91e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.9e-06	2.21e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—type 2 diabetes mellitus	5.88e-06	2.2e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	5.85e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	5.85e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	5.85e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	5.85e-06	2.19e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.76e-06	2.16e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.76e-06	2.16e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—SRC—type 2 diabetes mellitus	5.72e-06	2.14e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—SRC—type 2 diabetes mellitus	5.72e-06	2.14e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.67e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—SRC—type 2 diabetes mellitus	5.67e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—INS—type 2 diabetes mellitus	5.65e-06	2.12e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	5.6e-06	2.1e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.57e-06	2.09e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.56e-06	2.08e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.46e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.46e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.46e-06	2.05e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.46e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.43e-06	2.04e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—EGFR—type 2 diabetes mellitus	5.43e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.42e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.42e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.42e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.41e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.41e-06	2.03e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.37e-06	2.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	5.34e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.33e-06	2e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—SRC—type 2 diabetes mellitus	5.23e-06	1.96e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	5.21e-06	1.95e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.19e-06	1.94e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—TGFB1—type 2 diabetes mellitus	5.11e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—TGFB1—type 2 diabetes mellitus	5.11e-06	1.92e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.1e-06	1.91e-05	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—type 2 diabetes mellitus	5.09e-06	1.91e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.07e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.07e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—type 2 diabetes mellitus	5.06e-06	1.9e-05	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.04e-06	1.89e-05	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.04e-06	1.89e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.03e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.02e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	5.01e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—EGFR—type 2 diabetes mellitus	5.01e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—EGFR—type 2 diabetes mellitus	5.01e-06	1.88e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—type 2 diabetes mellitus	5e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.99e-06	1.87e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—EGFR—type 2 diabetes mellitus	4.97e-06	1.86e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.95e-06	1.85e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.95e-06	1.85e-05	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.93e-06	1.85e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.92e-06	1.84e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.89e-06	1.83e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—type 2 diabetes mellitus	4.87e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.86e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.86e-06	1.82e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	4.76e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	4.76e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.75e-06	1.78e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.7e-06	1.76e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—SRC—type 2 diabetes mellitus	4.68e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—TGFB1—type 2 diabetes mellitus	4.68e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	4.67e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.67e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.66e-06	1.75e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	4.64e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	4.64e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	4.64e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.64e-06	1.74e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.62e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	4.61e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.61e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.61e-06	1.73e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.6e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—EGFR—type 2 diabetes mellitus	4.58e-06	1.72e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.57e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.57e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.56e-06	1.71e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	4.53e-06	1.7e-05	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.49e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.48e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	4.48e-06	1.68e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	4.4e-06	1.65e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.38e-06	1.64e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.34e-06	1.63e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.3e-06	1.61e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.26e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.26e-06	1.6e-05	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.24e-06	1.59e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.21e-06	1.58e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.2e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.18e-06	1.57e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.18e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—type 2 diabetes mellitus	4.17e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	4.16e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	4.16e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	4.16e-06	1.56e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.15e-06	1.55e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.1e-06	1.54e-05	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—type 2 diabetes mellitus	4.1e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	4.09e-06	1.53e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	4.05e-06	1.52e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4e-06	1.5e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.97e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.97e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.96e-06	1.49e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.93e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.91e-06	1.47e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.9e-06	1.46e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.85e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—type 2 diabetes mellitus	3.85e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—type 2 diabetes mellitus	3.85e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—type 2 diabetes mellitus	3.85e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.84e-06	1.44e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—type 2 diabetes mellitus	3.82e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.81e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.81e-06	1.43e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.77e-06	1.41e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.77e-06	1.41e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.73e-06	1.4e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.67e-06	1.38e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.66e-06	1.37e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.61e-06	1.35e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.61e-06	1.35e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.58e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.57e-06	1.34e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—type 2 diabetes mellitus	3.55e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—type 2 diabetes mellitus	3.55e-06	1.33e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—type 2 diabetes mellitus	3.52e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—type 2 diabetes mellitus	3.52e-06	1.32e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.51e-06	1.31e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.27e-06	1.23e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—type 2 diabetes mellitus	3.25e-06	1.22e-05	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.21e-06	1.2e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.15e-06	1.18e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.11e-06	1.17e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	3.11e-06	1.17e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	3.1e-06	1.16e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	3.06e-06	1.15e-05	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—type 2 diabetes mellitus	2.98e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.97e-06	1.11e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.95e-06	1.1e-05	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.91e-06	1.09e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.89e-06	1.08e-05	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.87e-06	1.07e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.83e-06	1.06e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.77e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.76e-06	1.04e-05	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.72e-06	1.02e-05	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.7e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.69e-06	1.01e-05	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.66e-06	9.96e-06	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.65e-06	9.92e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.55e-06	9.56e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.5e-06	9.38e-06	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.49e-06	9.32e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.47e-06	9.24e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.42e-06	9.08e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.38e-06	8.93e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.38e-06	8.9e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.35e-06	8.8e-06	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.28e-06	8.53e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.07e-06	7.75e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.03e-06	7.6e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.86e-06	6.97e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	6.67e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	6.67e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	6.1e-06	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	8.18e-07	3.06e-06	CbGpPWpGaD
